Normal view MARC view ISBD view

DeBock, F

Alpha2-adrenoreceptor activation inhibits LTP and LTD in the basolateral amygdala: involvement of Gi/o-protein-mediated modulation of Ca2+-channels and inwardly rectifying K+-channels in LTD. [electronic resource] - The European journal of neuroscience Apr 2003 - 1411-24 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

ISSN: 0953-816X

Standard No.: 10.1046/j.1460-9568.2003.02544.x doi

Subjects--Topical Terms:
3',5'-Cyclic-AMP Phosphodiesterases--pharmacology
Adenylyl Cyclase Inhibitors
Adrenergic alpha-Agonists--pharmacology
Adrenergic alpha-Antagonists--pharmacology
Amygdala--physiology
Animals
Barium--pharmacology
Cadmium--pharmacology
Calcium Channel Blockers--pharmacology
Calcium Channels--metabolism
Clonidine--pharmacology
Colforsin--pharmacology
Cyclic Nucleotide Phosphodiesterases, Type 4
Electric Stimulation
Enzyme Inhibitors--pharmacology
Excitatory Postsynaptic Potentials--drug effects
Heterotrimeric GTP-Binding Proteins--classification
Imines--pharmacology
In Vitro Techniques
Isoquinolines--pharmacology
Long-Term Potentiation--physiology
Long-Term Synaptic Depression--physiology
Membrane Potentials--drug effects
Mice
Norepinephrine--pharmacology
Patch-Clamp Techniques--methods
Pertussis Toxin--pharmacology
Piperazines--pharmacology
Potassium Channel Blockers--pharmacology
Potassium Channels, Inwardly Rectifying--metabolism
Pyridines--pharmacology
Receptors, Adrenergic, alpha-2--metabolism
Serotonin Antagonists--pharmacology
Sulfonamides
Yohimbine--pharmacology
omega-Agatoxin IVA--pharmacology
omega-Conotoxins--pharmacology